PicoWay treatment to all subjects for Acne Scars

N/A

Waitlist Available

Research Sponsored by Syneron Medical

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up after 3 weeks up to 13 months

Awards & highlights

No Placebo-Only Group

Summary

Open-label, prospective study. Up to 60 healthy adult volunteers seeking facial acne scars treatment, males or females of 18 to 75 years of age, from up to 3 investigational sites.

Eligible Conditions

Acne Scars

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ after 3 weeks up to 13 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~after 3 weeks up to 13 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and after 3 weeks up to 13 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Efficacy of the PicoWayTM treatment

Secondary study objectives

Evaluate investigator satisfaction post treatments

Safety of the PicoWayTM

efficacy of the PicoWayTM fractional treatment by the investigator

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: PicoWay treatment to all subjectsExperimental Treatment1 Intervention

Subjects in this study will receive up to six (6) treatments in 3-8 weeks interval, with the PicoWay device-fractional handpiece 532nm and/or 1064nm according to the study protocol. Subjects will be followed by phone 7 days post first treatment by study staff, and will return for two follow-up (FU) visits at the clinic at: 6 weeks and 12 weeks following the last treatment.

Do I qualify?Apply below to find out